 send to a friend by email
2025-05-15
According to the financial statements of Jerusalem Pharmaceuticals JPH for the 1st Quarter of 2025, Net profit after tax of the period reached 2,110,563 USD Compared with Net profit after tax 302,217 USD for 2024, a net increase in profit of 598.36%.Total assets of the company reached 91,131,983 USD compared with total assets of 89,154,171 USD at the end of year 2024, a net increase of 2.22%.Total liabilities of the company reached 17,546,924 USD compared with total liabilities of 17,547,164 USD at the end of year 2024, a net decrease of 0.00%. Net ownership equity of the company reached 73,585,059 USD (Including Non-Controlling Interests of 1,018,569 USD) compared with total owner equity of 71,607,007 USD (Including Non-Controlling Interests of 1,010,817 USD) at the end of year 2024, a net increase of 2.76%.
|
-trade
